← Back to Search

Cancer Screening Test

Stool DNA Test for Colorectal Cancer

N/A
Recruiting
Led By Diana Redwood, PhD
Research Sponsored by Alaska Native Tribal Health Consortium
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing a new at-home colorectal cancer screening test in Alaska Native communities to see if it increases screening rates.

Who is the study for?
This trial is for Alaska Native adults who can get healthcare through the Alaska Tribal Health System, have visited it within the last three years, and are due for colorectal cancer screening. It's not open to those with certain genetic conditions or a history of bowel diseases, polyps, cancer, or colectomy.Check my eligibility
What is being tested?
The study tests an at-home stool DNA test (Cologuard®) to see if it increases colorectal cancer screening rates in Alaska Native communities. The research includes focus groups and a three-arm randomized trial comparing different levels of intervention intensity.See study design
What are the potential side effects?
As this is a non-invasive screening test rather than a medication or therapy, traditional side effects are not applicable. However, there may be indirect consequences related to receiving positive results such as anxiety or stress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal cancer screening
Secondary outcome measures
Diagnostic follow-up

Trial Design

3Treatment groups
Active Control
Group I: Usual CareActive Control1 Intervention
usual care (i.e., opportunistic screening recommendation at a clinic visit)
Group II: High IntensityActive Control1 Intervention
navigated tribal health worker outreach, a mailed MT-sDNA kit, mailed culturally appropriate educational material describing CRC screening options available and follow-up reminders
Group III: Medium IntensityActive Control1 Intervention
navigated tribal health worker outreach, a mailed MT-sDNA kit, mailed culturally appropriate educational material describing CRC screening options available and follow-up reminders

Find a Location

Who is running the clinical trial?

Mayo ClinicOTHER
3,207 Previous Clinical Trials
3,765,320 Total Patients Enrolled
Alaska Native Tribal Health ConsortiumLead Sponsor
14 Previous Clinical Trials
6,685 Total Patients Enrolled
Diana Redwood, PhDPrincipal InvestigatorAlaska Native Tribal Health Consortium

Media Library

Multi-Target Stool DNA Test (Cancer Screening Test) Clinical Trial Eligibility Overview. Trial Name: NCT04336397 — N/A
Colorectal Cancer Research Study Groups: Usual Care, High Intensity, Medium Intensity
Colorectal Cancer Clinical Trial 2023: Multi-Target Stool DNA Test Highlights & Side Effects. Trial Name: NCT04336397 — N/A
Multi-Target Stool DNA Test (Cancer Screening Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04336397 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap for participant enrollment in this experiment?

"Correct. Clinicaltrials.gov confirms that this clinical trial, which was initially published on April 29th 2021, is recruiting participants. Approximately 1540 patients need to be recruited from a single medical centre."

Answered by AI

Does this clinical investigation involve geriatric patients?

"Applicants between the ages of 45 and 75 are able to enroll in this clinical trial. Alternately, if you're under 18 years old there are 38 separate studies available while those over 65 have access to 1051 different trials."

Answered by AI

Are there any unfilled slots available for individuals wishing to participate in this trial?

"Absolutely, the records stored on clinicaltrials.gov prove that this experiment is currently recruiting subjects. The study was initially made visible to the public on April 29th 2021 and was recently updated in May 10th 2022. This trial requires a total of 1540 participants from just one medical centre."

Answered by AI

Are there any eligibility criteria for this clinical experiment?

"Qualifying for this study requires that patients are aged 45 to 75 and have colorectal cancer. Most critically, applicants must be active participants of the Alaska Tribal Health System with at least one visit in the past 3 years."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Yukon-Kuskokwim Health Corporation
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
2021. "Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04336397.
All > Alaska
~360 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top